Considering the growing interest in the potential efficacy of anti-rheumatic agents (e.g., TNF inhibitors) in patients with periodontitis (28) the present study aimed to test if blocking TNFR1 would reduce the risk of periodontitis using a drug target MR approach. This evidence concerns the gene TNF and periodontitis.